Search by
- Parties: The plaintiff was Pharmascience Inc. The defendants were Acorda Therapeutics Inc, Biogen Canada Inc, and Biogen International.
- Subject Matter: This action involved the Patented Medicines (NOC) Regulations.
- Date: The last hearing was set on November 13, 2025.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
Download documents
Plaintiff
Defendant
Court
Federal CourtCase Number
T-400-22Practice Area
Intellectual propertyAmount
Not specified/UnspecifiedWinner
Trial Start Date
24 February 2022